Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 14 20:31 · Ratings

Zenas BioPharma's Promising Pipeline and Strategic Moves Earn Buy Rating

TipRanksNov 14 19:57 · Ratings

Zenas BioPharma | 10-Q: Q3 2024 Earnings Report

SECNov 13 02:44 · Announcements

Zenas BioPharma 3Q Research and Development Expenses $33.5M >ZBIO

Dow JonesNov 12 20:16

Express News | Zenas Biopharma Inc: Qtrly Net Loss per Share $5.02

BreakingsNov 12 20:14

Express News | Zenas Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

BreakingsNov 12 20:10